FDA vaccine panel supports COVID shots for young children – CBS News
In a major step, a Food and Drug Administration panel has recommended Moderna’s two-dose COVID-19 vaccine for children under the age of 6, and Pfizer’s three-dose vaccine for children under the age of 5. CBS News correspondent Meg Oliver reports on the latest in the approval process. Then, Denis Nash, professor of epidemiology from the CUNY Graduate School of Public Health, discusses this major development.
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.